TINI 2TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

Sponsor:

Tanja Andrea Gruber

Code:

NCT05848687

Conditions

Lymphoblastic Leukemia

Eligibility Criteria

Sex: All

Age: 0 - 1

Healthy Volunteers: Not accepted

Interventions

Dexamethasone

Mitoxantrone

PEG asparaginase

Bortezomib

Vorinostat

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Tanja Andrea Gruber on 2026-06-03.